More than 4,000 patients have received treatment at Sultan Qaboos Comprehensive Cancer Care and Research Center during its first year of operation under the supervision of national and international experts specialized in the treatment of cancerous tumors.

From mid-July 2021, when the center was established, to the end of June 2022, 3,619 patients attended the Radiation Therapy department, 4,757 received chemotherapy treatment and 262 surgeries were performed.

The departments and units at SQCCCRC operated gradually with the aim of ensuring patients’ safety, activating the harmonization of medical, laboratory, pharmacy and radiological electronic systems, in addition to merging them with the center’s administrative system.

4,000 patients received healthcare services provided by the center within 6 treatment programs, where the breast program received the highest number of patient with 37.8%,  followed by Gastrointestinal Cancer program 26%, then the patients in head and neck program accounted for 16% of the total patients, and the rest of the patients were treated within the treatment programs for Urogenital Cancer by 7%, rare tumors by 6.8%, and gynecological tumors by 3.7%, and 37 patients received care within the palliative care program.

The center launched a number of advanced services for the treatment of cancer patients, including treatment with the CyberKnifeS7 radiosurgery device, the first of its kind in the region, which was used to treat a number of patients with small cancers in the brain and thoracic and having Trigeminal neuralgia. In addition, the radiation therapy department launched new radiotherapy services for breast cancer called (Partial Breast Irradiation) and (Hypo-SIB), which contributes to shortening the duration of treatment and lowering the treatment cost.

The surgical department and the advanced endoscopy unit were also provided with the latest equipment to enable the surgical team to perform complex, high-precision operations, including laparoscopic operations. Where the surgical team performed esophagectomy surgery laparoscopically fully for the first time in Oman.

In February 2022, The advanced endoscopy team Scoring the small bowel using the double balloon endoscopy for the first time in Sultanate, which is one of the most important endoscopes for examining and performing non-surgical interventions for the small bowel, and helps diagnose and treat intestinal bleeding. The Advanced Endoscopy Unit has performed 720 different types of endoscopy procedures since its commissioning in November 2021 until July 2022.

Since October 2021, the research laboratory has started conducting Comprehensive Genomic Profiling of tumor tissue for the first time in the sultanate, which identifies the patient’s genetic mutations that cause the growth of cancerous cells and determines the most appropriate treatment for the case in a short time.

On the diagnosis side 8571 radiology and nuclear medicine exams have been conducted within a year. In addition, 4738 Rehabilitation sessions have been conducted (2896 Physiotherapy, 1309 Occupational Therapy, 533 speech and Language), and the Department of Genomics provided genetic counseling service to 468 patients from its operation in September 2021 to June 30, 2022,